• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,986.19 99.41
(0.23%)
Dow Jones
6,065.31 22.07
(0.37%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,850.63 -34.29
(-0.39%)
Forex
USD-INR
85.49 -0.11
(-0.13%)
EUR-INR
97.91 0.18
(0.18%)
GBP-INR
115.53 -0.11
(-0.10%)
JPY-INR
0.59 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Murae Organisor Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
542724
INE060601031
1.1214117
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.25
217.5
EPS(TTM)
Face Value()
Div & Yield %
0.04
1
0
 

Royal India Corporation reports standalone net profit of Rs 10.90 crore in the March 2025 quarter
May 31,2025
Net profit of Royal India Corporation reported to Rs 10.90 crore in the quarter ended March 2025 as against net loss of Rs 2.58 crore during the previous quarter ended March 2024. Sales reported to Rs 70.22 crore in the quarter ended March 2025. There were no Sales reported during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 10.83 crore in the year ended March 2025 as against net loss of Rs 8.24 crore during the previous year ended March 2024. Sales rose 662.90% to Rs 220.02 crore in the year ended March 2025 as against Rs 28.84 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales70.220 0 220.0228.84 663
OPM %8.170 -5.78-8.46 -
PBDT11.56-3.41 LP 11.50-9.03 LP
PBT11.55-3.41 LP 11.48-9.05 LP
NP10.90-2.58 LP 10.83-8.24 LP